These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 34785416)

  • 1. Review of anticancer potentials and structure-activity relationships (SAR) of rhodanine derivatives.
    Yin LJ; Bin Ahmad Kamar AKD; Fung GT; Liang CT; Avupati VR
    Biomed Pharmacother; 2022 Jan; 145():112406. PubMed ID: 34785416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Importance of Rhodanine Scaffold in Medicinal Chemistry: A Comprehensive Overview.
    Mermer A
    Mini Rev Med Chem; 2021; 21(6):738-789. PubMed ID: 33334286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticancer Profile of Rhodanines: Structure-Activity Relationship (SAR) and Molecular Targets-A Review.
    Szczepański J; Tuszewska H; Trotsko N
    Molecules; 2022 Jun; 27(12):. PubMed ID: 35744873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A conceptual review of rhodanine: current applications of antiviral drugs, anticancer and antimicrobial activities.
    Mousavi SM; Zarei M; Hashemi SA; Babapoor A; Amani AM
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1132-1148. PubMed ID: 30942110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug screening of rhodanine derivatives for antibacterial activity.
    Maddila S; Gorle S; Jonnalagadda SB
    Expert Opin Drug Discov; 2020 Feb; 15(2):203-229. PubMed ID: 31777321
    [No Abstract]   [Full Text] [Related]  

  • 6. New N-ribosides and N-mannosides of rhodanine derivatives with anticancer activity on leukemia cell line: Design, synthesis, DFT and molecular modelling studies.
    Khodair AI; Awad MK; Gesson JP; Elshaier YAMM
    Carbohydr Res; 2020 Jan; 487():107894. PubMed ID: 31865252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Comprehensive Review on the Biological and Pharmacological Activities of Rhodanine Based Compounds for Research and Development of Drugs.
    Liu J; Wu Y; Piao H; Zhao X; Zhang W; Wang Y; Liu M
    Mini Rev Med Chem; 2018; 18(11):948-961. PubMed ID: 27697041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of new rhodanine analogues bearing 2-chloroquinoline and benzo[h]quinoline scaffolds as anticancer agents.
    Ramesh V; Ananda Rao B; Sharma P; Swarna B; Thummuri D; Srinivas K; Naidu VG; Jayathirtha Rao V
    Eur J Med Chem; 2014 Aug; 83():569-80. PubMed ID: 24996143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rhodanine derivatives: An insight into the synthetic and medicinal perspectives as antimicrobial and antiviral agents.
    Chaurasyia A; Chawla P; Monga V; Singh G
    Chem Biol Drug Des; 2023 Mar; 101(3):500-549. PubMed ID: 36447391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent developments with rhodanine as a scaffold for drug discovery.
    Kaminskyy D; Kryshchyshyn A; Lesyk R
    Expert Opin Drug Discov; 2017 Dec; 12(12):1233-1252. PubMed ID: 29019278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rhodanine as a scaffold in drug discovery: a critical review of its biological activities and mechanisms of target modulation.
    Tomašić T; Peterlin Mašič L
    Expert Opin Drug Discov; 2012 Jul; 7(7):549-60. PubMed ID: 22607309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of facile amides-functionalized rhodanine-3-acetic acid derivatives as potential anticancer agents by disrupting microtubule dynamics.
    Zhou X; Liu J; Meng J; Fu Y; Wu Z; Ouyang G; Wang Z
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1996-2009. PubMed ID: 34525898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rhodanine Derivatives as Anticancer Agents: QSAR and Molecular Docking Studies.
    Molnar M; Lončarić M; Opačak-Bernardi T; Glavaš-Obrovac L; Rastija V
    Anticancer Agents Med Chem; 2023; 23(7):839-846. PubMed ID: 36305127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2H-chromene derivatives bearing thiazolidine-2,4-dione, rhodanine or hydantoin moieties as potential anticancer agents.
    Azizmohammadi M; Khoobi M; Ramazani A; Emami S; Zarrin A; Firuzi O; Miri R; Shafiee A
    Eur J Med Chem; 2013 Jan; 59():15-22. PubMed ID: 23202485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rhodanine as a privileged scaffold in drug discovery.
    Tomasić T; Masic LP
    Curr Med Chem; 2009; 16(13):1596-629. PubMed ID: 19442136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benzimidazole as a Privileged Scaffold in Drug Design and Discovery.
    Kumar R; Marianesan AB; Pathak S
    Curr Top Med Chem; 2024; 24(17):1504-1528. PubMed ID: 38818908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological evaluation of purine-pyrazole hybrids incorporating thiazole, thiazolidinone or rhodanine moiety as 15-LOX inhibitors endowed with anticancer and antioxidant potential.
    Afifi OS; Shaaban OG; Abd El Razik HA; Shams El-Dine SEA; Ashour FA; El-Tombary AA; Abu-Serie MM
    Bioorg Chem; 2019 Jun; 87():821-837. PubMed ID: 30999135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of (beta-carboxyethyl)-rhodanine derivatives exhibiting peroxisome proliferator-activated receptor gamma activity.
    Choi J; Ko Y; Lee HS; Park YS; Yang Y; Yoon S
    Eur J Med Chem; 2010 Jan; 45(1):193-202. PubMed ID: 19879669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of Novel Rhodanine Analogs as Anticancer Agents: Design, Synthesis, Evaluation and CoMSIA Study.
    Krithika U; Prabitha P; Mandal SP; Yuvaraj S; Priya D; Wadhwani AD; Prashantha Kumar BR
    Med Chem; 2021; 17(3):216-229. PubMed ID: 32520692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting cancer using scaffold-hopping approaches: illuminating SAR to improve drug design.
    Shivani ; Abdul Rahaman TA; Chaudhary S
    Drug Discov Today; 2024 Sep; 29(9):104115. PubMed ID: 39067613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.